Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00592436
(New protocol developed for recruitment of children for all child studies)
: January 14, 2008
Last Update Posted
: May 6, 2015
Massachusetts General Hospital
Information provided by (Responsible Party):
Joseph Biederman, MD, Massachusetts General Hospital
The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential pediatric subjects for appropriate ADHD clinical research studies.
Condition or disease
The ADHD Clinical Research Program at Massachusetts General Hospital currently offers a range of protocols addressing different aspects of ADHD in children and adolescents. Although these protocols have received prior IRB approval, potential participants present with a widely varied set of complaints not always discernable in a telephone screening interview. This state of affairs often makes it difficult to ask subjects and their parents to sign a specific protocol's consent form without obtaining additional clinical information. Because of this, we are proposing that potential subjects and their parents undergo an in-depth clinical assessment that will allow them to be screened by a clinician for eligibility to a diverse clinical research program.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
6 Years to 17 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Children with symptoms of ADHD
Males and females ages 6-17
Family/guardian contacting the Clinical Research Program in Pediatric Psychopharmacology, with concerns regarding ADHD symptoms in his/her child
History of significant head trauma with loss of consciousness, organic brain disorders, seizures, or neurological intervention
Any significant medical condition, in the judgment of the investigator
Pregnancy or lactation
Subjects with current, uncontrolled (within the past 3 months) illicit drug or alcohol dependence
Sensory difficulties such as deafness or blindness